High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size, Share, and Opportunities for Forecast to 2029

The global HPAPI market is set to witness a high growth rate of 9% in the next 5 years. Rising incidence of cancer and other chronic diseases, increasing R&D activities & investments, advancements in oncology therapies, growing demand for targeted therapies, advances in manufacturing technologies, innovation and pipeline expansion, and increasing outsourcing to CDMOs are […]

全球人源化抗体药（HPAPI）市场预计在未来五年将迎来高达9%的高速增长。癌症及其他慢性疾病的发病率上升、研发活动的增加及投资增长、肿瘤学疗法的进步、靶向治疗需求的增长、制造技术的进步、创新与管线拓展，以及向合同研究组织（CDMO）外包的增加等因素均预示着这一趋势。